McArdle B. Myopathy due to a defect in muscle glycogen breakdown. Clin Sci. 1951. 10:13-33.
Nogales-Gadea G, Consuegra-García I, Rubio JC, Arenas J, Cuadros M, Camara Y, et al. A transcriptomic approach to search for novel phenotypic regulators in McArdle disease. PLoS One. 2012. 7(2):e31718. [QxMD MEDLINE Link]. [Full Text].
García-Benítez S, Fleck SJ, Naclerio F, Martín MA, Lucia A. Resistance (weight lifting) training in an adolescent with McArdle disease. J Child Neurol. 2013 Jun. 28(6):805-8. [QxMD MEDLINE Link].
Rubio J, Gomez-Gallego F, Santiago C, et al. Genotype modulators of clincal severity in McArdle disease. Neuroscience Letters. June 2007. 422:217-222.
Lucia A, Ruiz JR, Santalla A, Nogales-Gadea G, Rubio JC, García-Consuegra I, et al. Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J Neurol Neurosurg Psychiatry. 2012 Mar. 83(3):322-8. [QxMD MEDLINE Link].
Santalla A, Nogales-Gadea G, Encinar AB, et al. Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update. BMC Genomics. 2017 Nov 14. 18 (Suppl 8):819. [QxMD MEDLINE Link].
Nogales-Gadea G, Godfrey RJ, Santalla A, Coll-Cantí J, Pintos-Morell G, Pinós T, et al. Genes and exercise intolerance: Insights from McArdle disease. Physiol Genomics. 2015 Oct 13. physiolgenomics.00076.2015. [QxMD MEDLINE Link].
de Luna N, Brull A, Lucia A, Santalla A, Garatachea N, Martí R, et al. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?. Neuromuscul Disord. 2014 Dec. 24 (12):1079-86. [QxMD MEDLINE Link].
Martinuzzi A, Sartori E, Fanin M, et al. Phenotype modulators in myophosphorylase deficiency. Ann Neurol. 2003 Apr. 53(4):497-502. [QxMD MEDLINE Link].
Gómez-Gallego F, Santiago C, Morán M, Pérez M, Maté-Muñoz JL, del Valle MF, et al. The I allele of the ACE gene is associated with improved exercise capacity in women with McArdle disease. Br J Sports Med. 2008 Feb. 42 (2):134-40. [QxMD MEDLINE Link].
Lucia A, Nogales-Gadea G, Perez M, et al. McArdle disease: what do neurologists need to know?. Nat Clin Pract Neurol. 2008 Oct. 4(10):568-77. [QxMD MEDLINE Link].
Kazemi-Esfarjani P, Skomorowska E, Jensen TD, Haller RG, Vissing J. A nonischemic forearm exercise test for McArdle disease. Ann Neurol. 2002 Aug. 52(2):153-9. [QxMD MEDLINE Link].
Hogrel JY, van den Bogaart F, Ledoux I, Ollivier G, Petit F, Koujah N, et al. Diagnostic power of the non-ischaemic forearm exercise test in detecting glycogenosis type V. Eur J Neurol. 2015 Jun. 22 (6):933-40. [QxMD MEDLINE Link].
Buckley JP, Quinlivan RM, Sim J, Eston RG, Short DS. Heart rate and perceived muscle pain responses to a functional walking test in McArdle disease. J Sports Sci. 2014. 32 (16):1561-9. [QxMD MEDLINE Link].
Semplicini C, Hézode-Arzel M, Laforêt P, Béhin A, Leonard-Louis S, Hogrel JY, et al. The role of electrodiagnosis with long exercise test in mcardle disease. Muscle Nerve. 2018 Jan 19. [QxMD MEDLINE Link].
Vorgerd M, Zange J, Kley R, Grehl T, Husing A, Jager M. Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study. Arch Neurol. 2002 Jan. 59(1):97-101. [QxMD MEDLINE Link].
Martinuzzi A, Liava A, Trevisi E, et al. Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease. Muscle Nerve. 2008 Mar. 37(3):350-7. [QxMD MEDLINE Link].
Howell JM, Dunton E, Creed KE, Quinlivan R, Sewry C. Investigating sodium valproate as a treatment for McArdle disease in sheep. Neuromuscul Disord. 2015 Feb. 25 (2):111-9. [QxMD MEDLINE Link].
de Luna N, Brull A, Guiu JM, Lucia A, Martin MA, Arenas J, et al. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro. Dis Model Mech. 2015 May. 8 (5):467-72. [QxMD MEDLINE Link].
Quinlivan R, Martinuzzi A, Schoser B. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). Cochrane Database Syst Rev. 2014 Nov 12. CD003458. [QxMD MEDLINE Link].
Andersen ST, Vissing J. Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity. J Neurol Neurosurg Psychiatry. 2008 Dec. 79(12):1359-63. [QxMD MEDLINE Link].
Gamez J, Rubio JC, Martin MA, Fernandez-Cadenas I, Garcia-Arumi E, Andreu AL. Two novel mutations in the muscle glycogen phosphorylase gene in McArdle's disease. Muscle Nerve. 2003 Sep. 28(3):380-2. [QxMD MEDLINE Link].
Vissing J, Haller RG. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N Engl J Med. 2003 Dec 25. 349(26):2503-9. [QxMD MEDLINE Link].
Bollig G. McArdle's disease (glycogen storage disease type V) and anesthesia--a case report and review of the literature. Paediatr Anaesth. 2013 Sep. 23 (9):817-23. [QxMD MEDLINE Link].
Andersen ST, Duno M, Schwartz M, Vissing J. Do carriers of PYGM mutations have symptoms of McArdle disease?. Neurology. 2006 Aug 22. 67(4):716-8. [QxMD MEDLINE Link].
Bartram C, Flannery A, Evershed RP, et al. Interrelationships between metabolism of glycogen phosphorylase and pyridoxal phosphate--implications in McArdle’s disease. Advances in Food & Nutrition Research. 1996. 40:135-47.
Beynon RJ, Bartram C, Hopkins P, Toescu V, Gibson H, Phoenix J. McArdle's disease: molecular genetics and metabolic consequences of the phenotype. Muscle Nerve. 1995. 3:S18-22. [QxMD MEDLINE Link].
Busch V, Gempel K, Hack A. Treatment of glycogenosis type V with ketogenic diet. Ann Neurol. 2005 Aug. 58(2):341. [QxMD MEDLINE Link].
Busch V, Gempel K, Hack A, Müller K, Vorgerd M, Lochmuller H. Treatment of glycogenosis type V with ketogenic diet. Ann Neurol. 2005 Aug. 58(2):341. [QxMD MEDLINE Link].
Cornelio F, Bresolin N, DiMauro S, Mora M, et al. Congenital myopathy due to phosphorylase deficiency. Neurology. 1983 Oct. 33(10):1383-5. [QxMD MEDLINE Link].
DiMauro S, Andreu AL, Bruno C, Hadjigeorgiou GM. Myophosphorylase deficiency (glycogenosis type V; McArdle’s disease). Curr Mol Med. Mar 2002. 2(2):189-96.
DiMauro S, Bresolin N. Phosphorylase deficiency. Myology. 1585-1601.
DiMauro S, Hartlage PL. Fatal infantile form of muscle phosphorylase deficiency. Neurology. 1978 Nov. 28(11):1124-9. [QxMD MEDLINE Link].
DiMauro S, Tsujino S. Nonlysosomal Glycogenoses. Myology: Basic and Clinical. 2nd ed. 1994. 1557-1561.
Gautron S, Daegelen D, Mennecier F, Dubocq D, Kahn A, Dreyfus JC. Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis. J Clin Invest. 1987 Jan. 79(1):275-81. [QxMD MEDLINE Link].
Gordon N. Glycogenosis type V or McArdle's disease. Dev Med Child Neurol. 2003 Sep. 45(9):640-4. [QxMD MEDLINE Link].
Grunfeld JP, Ganeval D, Chanard J, Fardeau M, Dreyfus JC. Acute renal failure in McArdle's disease. Report of two cases. N Engl J Med. 1972 Jun 8. 286(23):1237-41. [QxMD MEDLINE Link].
Haller RG, Wyrick P, Taivassalo T, Vissing J. Aerobic conditioning: an effective therapy in McArdle's disease. Ann Neurol. 2006 Jun. 59(6):922-8. [QxMD MEDLINE Link].
McConchie SM, Coakley J, Edwards RH, Beynon RJ. Molecular heterogeneity in McArdle's disease. Biochim Biophys Acta. 1990 Nov 14. 1096(1):26-32. [QxMD MEDLINE Link].
Milstein JM, Herron TM, Haas JE. Fatal infantile muscle phosphorylase deficiency. J Child Neurol. 1989 Jul. 4(3):186-8. [QxMD MEDLINE Link].
Miranda AF, Nette EG, Hartlage PL, DiMauro S. Phosphorylase isoenzymes in normal and myophosphorylase-deficient human heart. Neurology. 1979 Nov. 29(11):1538-41. [QxMD MEDLINE Link].
Moses SW. Muscle glycogenosis. J Inherit Metab Dis. 1990. 13(4):452-65. [QxMD MEDLINE Link].
Nielsen JN, Vissing J, Wojtaszewski JF, Haller RG, Begum N, Richter EA. Decreased insulin action in skeletal muscle from patients with McArdle's disease. Am J Physiol Endocrinol Metab. 2002 Jun. 282(6):E1267-75. [QxMD MEDLINE Link].
Nogales-Gadea G, Arenas J, Andreu AL. Molecular genetics of McArdle's disease. Curr Neurol Neurosci Rep. 2007 Jan. 7(1):84-92. [QxMD MEDLINE Link].
Ollivier K, Hogrel JY, Gomez-Merino D, Romero NB, Laforet P, Eymard B. Exercise tolerance and daily life in McArdle's disease. Muscle Nerve. 2005 May. 31(5):637-41. [QxMD MEDLINE Link].
Pourmand R, Sanders DB, Corwin HM. Late-onset Mcardle's disease with unusual electromyographic findings. Arch Neurol. 1983 Jun. 40(6):374-7. [QxMD MEDLINE Link].
Quinlivan R, Beynon RJ. Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V). Cochrane Database Syst Rev. 2004. (3):CD003458. [QxMD MEDLINE Link].
Schmid R, Mahler R. Chronic progressive myopathy with myoglobinuria: demonstration of a glycogenolytic defect in the muscle. J Clin Invest. 1959 Nov. 38:2044-58. [QxMD MEDLINE Link].
Servidei S, DiMauro S. Disorders of glycogen metabolism of muscle. Neurol Clin. 1989 Feb. 7(1):159-78. [QxMD MEDLINE Link].
Servidei S, Shanske S, Zeviani M, Lebo R, Fletterick R, DiMauro S. McArdle's disease: biochemical and molecular genetic studies. Ann Neurol. 1988 Dec. 24(6):774-81. [QxMD MEDLINE Link].
Tsujino S, Shanske S, DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease). N Engl J Med. 1993 Jul 22. 329(4):241-5. [QxMD MEDLINE Link].
Tsujino S, Shanske S, Nonaka I, DiMauro S. The molecular genetic basis of myophosphorylase deficiency (McArdle's disease). Muscle Nerve. 1995. 3:S23-7. [QxMD MEDLINE Link].
De Castro M, Johnston J, Biesecker L. Determining the prevalence of McArdle disease from gene frequency by analysis of next-generation sequencing data. Genet Med. 2015 Dec. 17 (12):1002-6. [QxMD MEDLINE Link].
Nogales-Gadea G, Santalla A, Brull A, de Luna N, Lucia A, Pinós T. The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications. J Inherit Metab Dis. 2015 Mar. 38 (2):221-30. [QxMD MEDLINE Link].
Manfredi G, Silvestri G, Servidei S, Ricci E, Mirabella M, Bertini E, et al. Manifesting heterozygotes in McArdle's disease: clinical, morphological and biochemical studies in a family. J Neurol Sci. 1993 Mar. 115 (1):91-4. [QxMD MEDLINE Link].
Schmidt B, Servidei S, Gabbai AA, Silva AC, de Sousa Bulle de Oliveira A, DiMauro S. McArdle's disease in two generations: autosomal recessive transmission with manifesting heterozygote. Neurology. 1987 Sep. 37 (9):1558-61. [QxMD MEDLINE Link].